The Constipation Protocol: Stepwise Management Clinicians Actually Use
Updated September 2026 · Medically reviewed content · 8 min read
Constipation is the second most commonly reported GI side effect of GLP-1 receptor agonists, affecting 10–25% of patients depending on the study. Unlike nausea — which tends to improve with time — constipation can persist or worsen as treatment continues, particularly after dose increases. The good news is that it's manageable with a structured stepwise approach. The bad news is that most patients get the management order wrong, jumping to stimulant laxatives when simpler interventions would have worked.
This is the protocol clinicians actually follow, organized in escalation steps from least to most aggressive intervention. Start at Step 1 and advance only if the current step hasn't produced results within the specified timeframe.
Why GLP-1s Cause Constipation
Understanding the mechanism matters because it determines which interventions work and which don't.
GLP-1 receptor agonists slow gastric emptying — that's their primary GI effect and part of how they produce satiety. But the slowing doesn't stop at the stomach. The entire gastrointestinal tract has GLP-1 receptors, and activation of these receptors reduces motility throughout the colon. Food moves through the system more slowly. Water is reabsorbed for a longer period. The result is drier, harder stools that are more difficult to pass.
This is fundamentally different from constipation caused by dehydration alone, or by low-fiber diets, or by sedentary lifestyle — though all of these can compound the GLP-1 effect. The distinction matters: interventions that target motility (osmotic laxatives, physical activity) work better than interventions that target stool consistency alone (fiber without adequate water).
The Four-Step Protocol
Step 1: Foundation — Hydration + Fiber + Movement
Try for 5–7 days before escalating
This is where every patient should start, and where many will find relief. The three components work synergistically — doing only one without the others is significantly less effective.
Hydration: Increase water intake to 80–100 ounces per day. This is meaningfully higher than the general recommendation of 64 ounces, and it needs to be specifically water — coffee, tea, and alcohol are all mild diuretics that can worsen dehydration. Track your intake for the first week. Most patients who think they're drinking enough are consuming 40–50 ounces when they actually measure.
Fiber: Target 25–35 grams of dietary fiber per day, increased gradually over 5–7 days (not overnight — rapid fiber increases cause bloating and gas, which are already potential GLP-1 effects). Soluble fiber sources (oats, chia seeds, psyllium husk, lentils) are generally better tolerated than insoluble fiber (raw vegetables, wheat bran) during GLP-1 therapy. If you can't reach fiber targets through food — common when appetite is reduced — a psyllium fiber supplement (Metamucil or generic equivalent) once daily is a reliable addition.
Physical activity: 15–30 minutes of walking daily. Walking is specifically effective for colonic motility — the mechanical motion of the torso stimulates the gastrocolic reflex and assists transit. This doesn't need to be vigorous exercise. A post-meal walk is particularly effective because it pairs the gastrocolic reflex from eating with the mechanical stimulus of movement.
Critical point: Fiber without adequate water makes constipation worse, not better. The fiber absorbs water and bulks stool — if there isn't enough water to absorb, you end up with a larger, drier mass that's harder to pass. Always increase water first, then add fiber.
Step 2: Osmotic Laxative
Add if Step 1 hasn't resolved constipation after 5–7 days
Polyethylene glycol 3350 (MiraLAX or generic): 17 grams (one capful) dissolved in 8 ounces of water, once daily. This is the first-line pharmacologic intervention for GLP-1-related constipation in most clinical guidelines. PEG 3350 is an osmotic agent — it draws water into the colon, softening stool and increasing its volume, which triggers the urge to defecate.
Why osmotic first: Osmotic laxatives work with the body's natural motility rather than forcing contractions. They're safe for daily use for extended periods (weeks to months), non-habit-forming, and have minimal systemic absorption. They address the core mechanism of GLP-1 constipation (excessive water reabsorption from slow transit) directly.
Timing: Take it in the morning for most patients, as the effect typically occurs 12–48 hours after ingestion. Some clinicians recommend splitting to half a capful twice daily for more consistent effect.
Alternative osmotic agents: Magnesium citrate is a stronger osmotic option for patients who don't respond to PEG alone. Start with 150 mg daily and adjust based on effect. Lactulose is another option but tends to cause more bloating and gas. Milk of magnesia (magnesium hydroxide) works quickly but is better as a short-term rescue than daily maintenance.
What to expect: Most patients see improvement within 1–3 days of starting PEG. If there's no improvement after 5–7 days of consistent daily use at full dose, escalate to Step 3.
Need provider guidance on managing side effects?
Embody includes provider messaging for symptom management. Injectable semaglutide from $69–99 first month (ongoing ~$299/mo).
Check Embody →Compounded semaglutide injection — not FDA-approved. Injectable semaglutide only.
Step 3: Stimulant Laxative (Short-Term) or Prescription Intervention
Escalate if osmotic laxative alone hasn't worked after 7+ days
Stimulant laxatives (bisacodyl/Dulcolax or sennosides/Senokot) work by directly stimulating colonic contractions. They're effective but should not be the first-line or daily-use intervention for GLP-1 constipation. They're appropriate as a rescue therapy — when you need results now — while the osmotic regimen builds up its effect, or as an intermittent addition (2–3 times per week maximum) when the osmotic alone isn't sufficient.
Why not daily: Chronic daily stimulant laxative use can lead to dependence (the colon loses its ability to contract without the stimulus) and electrolyte disturbances. This isn't a concern with short-term or intermittent use, but it's the reason clinicians prefer osmotics for daily maintenance.
Prescription options your provider may consider:
Linaclotide (Linzess): A prescription medication specifically approved for chronic constipation. It activates chloride channels in the intestinal lining, increasing fluid secretion and accelerating transit. Many GI specialists consider this the best pharmacologic option for persistent GLP-1-related constipation that doesn't respond to over-the-counter agents. 72 mcg or 145 mcg daily.
Lubiprostone (Amitiza): Another prescription option that increases intestinal fluid secretion. 24 mcg twice daily. Less commonly prescribed than linaclotide for this specific indication but effective for some patients.
Prucalopride (Motegrity): A prokinetic that directly stimulates colonic motility — addressing the core slowed-transit mechanism. This is the most mechanistically appropriate prescription for GLP-1-related constipation, though it's less widely prescribed and may require a GI specialist referral.
Step 4: Clinical Evaluation — When Constipation Needs Investigation
Escalate to your prescriber if Steps 1–3 fail or warning signs appear
Persistent constipation despite the first three steps, or constipation accompanied by warning signs, requires clinical evaluation beyond medication management.
Seek evaluation if: You've had no bowel movement for 7+ days despite Step 1–3 interventions. You have new abdominal distension (visible swelling). You're unable to pass gas (a potential sign of obstruction). You see blood in your stool or on toilet paper (requires evaluation regardless of GLP-1 use). You have severe, constant abdominal pain (not just cramping or pressure).
What the evaluation looks like: Your provider will likely check an abdominal X-ray to assess stool burden and rule out obstruction. Blood work may include electrolytes (particularly potassium and magnesium, which affect gut motility). If constipation is severe and refractory, a referral to gastroenterology for motility testing may be appropriate.
The dose question: Severe, refractory constipation is one of the clinical reasons a prescriber may pause titration, reduce dose, or in rare cases, discontinue a GLP-1. This is a reasonable discussion to have — the medication isn't worth taking if it creates a GI emergency. Most patients don't reach this point, but it's important to know the option exists.
Common Mistakes That Make It Worse
Adding fiber without adding water. The single most common mistake. Fiber is a bulking agent. Without adequate water, it creates a denser, more compacted mass. Every time you increase fiber, increase water by at least 16 ounces.
Waiting too long to start an osmotic. Patients often try to tough it out with diet and exercise alone for weeks, allowing stool to become increasingly compacted and harder to pass. If Step 1 hasn't worked after 5–7 days, starting PEG 3350 is not an overreaction — it's the protocol.
Using stimulant laxatives as the first and only intervention. Stimulants work quickly, which makes them feel like the "real" solution. But using them daily without the osmotic foundation leads to a cycle of constipation-rescue-constipation that's harder to break than the original problem.
Reducing food intake because "less in = less stuck." Counterintuitively, eating more (particularly fiber-rich foods with adequate water) helps constipation because it maintains the gastrocolic reflex — the signal that eating triggers to move things downstream. An empty GI tract doesn't move efficiently. Eating stimulates motility. Skip meals and transit slows further.
Ignoring it because it seems minor. Mild constipation is not an emergency. Untreated constipation that progresses over weeks can become compacted enough to cause obstruction, which is an emergency. The protocol exists to prevent this progression.
GobyMeds: No auto-renew, free consult for side effect management
Compounded semaglutide from $99/mo (12-week bundle $299). Discuss constipation management with the consulting provider before starting.
See GobyMeds Plans →Compounded medication — not FDA-approved. Dispensed by licensed 503A pharmacies.
How Long Does GLP-1 Constipation Last?
Unlike nausea — which often improves as the body adapts to the medication — constipation can persist for the duration of treatment because the underlying mechanism (slowed GI transit) is an ongoing effect of GLP-1 receptor activation, not a transient adaptation period. That said, many patients find that the severity decreases after the first 3–6 months as they dial in their fiber, hydration, and laxative regimen.
The practical takeaway: treat constipation management as a long-term protocol, not a short-term problem. Having a daily regimen (adequate water, fiber, and a maintenance osmotic if needed) prevents the cycle of constipation → rescue → constipation that many patients fall into.